title: Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
authors.affiliation: Abteilung Nephrologie, Medizinische Hochschule Hannover, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Kliem
authors.forename: J
authors.initials: J
authors.lastname: Radermacher
authors.forename: M
authors.initials: M
authors.lastname: Hiss
authors.forename: M
authors.initials: M
authors.lastname: Pethig
authors.forename: M
authors.initials: M
authors.lastname: Burg
authors.forename: R
authors.initials: R
authors.lastname: Brunkhorst
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy* / Q000401:mortality; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012086:Reoperation; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone